(NASDAQ: DTIL) Precision Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.65%.
Precision Biosciences's earnings in 2025 is -$83,602,000.On average, 6 Wall Street analysts forecast DTIL's earnings for 2025 to be -$85,492,787, with the lowest DTIL earnings forecast at -$86,654,079, and the highest DTIL earnings forecast at -$83,517,531. On average, 6 Wall Street analysts forecast DTIL's earnings for 2026 to be -$42,155,143, with the lowest DTIL earnings forecast at -$67,686,319, and the highest DTIL earnings forecast at -$13,919,589.
In 2027, DTIL is forecast to generate -$43,169,284 in earnings, with the lowest earnings forecast at -$57,033,194 and the highest earnings forecast at -$17,538,682.